FDA Inspection 1210451 — Central Boeki U.S.A. LTD.
The FDA completed an inspection of Central Boeki U.S.A. LTD. on July 13, 2023 in Long Island City, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 13, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Long Island City, NY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1524 | 21 CFR 123.11(b) | Sanitation monitoring |
| 18145 | 21 CFR 117.35(c) | Pest control |
| 18165 | 21 CFR 117.93 | Storage and Distribution |
| 6021 | 21 CFR 123.10 | HACCP training or qualification |
| 904 | 21 CFR 123.6(b) | No HACCP plan |
| 945 | 21 CFR 123.12(a)(2) | Importer verification |